Perrigo (PRGO) Current Assets (2013 - 2026)
Perrigo (PRGO) posted quarterly Current Assets of $2.7 billion for Q1 2026, up 7.08% year-over-year from $2.5 billion in Q1 2025, and down 3.04% quarter-over-quarter from $2.8 billion in Q4 2025.
Perrigo (PRGO) Current Assets (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Current Assets for 14 consecutive years, with $2.7 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 7.08% year-over-year to $2.7 billion; the TTM figure through Mar 2026 stood at $2.7 billion (up 7.08% YoY), while the FY2025 annual figure was $2.8 billion, up 12.71% from the prior year.
- Current Assets retreated to $2.7 billion in Q1 2026 per PRGO's latest filing, from $2.8 billion in the prior quarter.
- Across five years, Current Assets topped out at $3.9 billion in Q2 2022 and bottomed at $2.5 billion in Q4 2024.
- Historically, Current Assets has averaged $2.9 billion across 5 years, with a median of $2.8 billion in 2023.
- Annual changes were most pronounced in 2022 — Current Assets sank 40.01% — and 2024, when it surged 34.08%.
- Perrigo's Current Assets stood at $2.7 billion in 2022, then climbed by 4.15% to $2.8 billion in 2023, then retreated by 12.39% to $2.5 billion in 2024, then increased by 12.71% to $2.8 billion in 2025, then declined by 3.04% to $2.7 billion in 2026.
- Business Quant data shows PRGO's Current Assets at $2.7 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.22 Bn |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | 2.45 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 2.45 Bn |
| Mar 28, 2026 | 2.71 Bn |
| Dec 31, 2025 | 2.80 Bn |
| Sep 27, 2025 | 2.88 Bn |
| Jun 28, 2025 | 2.62 Bn |
| Mar 29, 2025 | 2.53 Bn |
| Dec 31, 2024 | 2.48 Bn |
| Sep 28, 2024 | 3.71 Bn |
| Jun 29, 2024 | 2.96 Bn |
| Mar 30, 2024 | 2.81 Bn |
| Dec 31, 2023 | 2.83 Bn |
| Sep 30, 2023 | 2.77 Bn |
| Jul 1, 2023 | 2.77 Bn |
| Apr 1, 2023 | 2.74 Bn |
| Dec 31, 2022 | 2.72 Bn |
| Oct 1, 2022 | 2.58 Bn |
| Jul 2, 2022 | 2.65 Bn |
| Apr 2, 2022 | 3.94 Bn |
| Dec 31, 2021 | 3.86 Bn |
| Oct 2, 2021 | 4.23 Bn |